Atlas Trials

SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients

Clinical trial NCT03065179 · COMPLETED

Trial details

NCT number
NCT03065179
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Cancer MetastaticKidney CancerKidney Cancer, Stage IV
Start date
2017-03-01
Primary completion
2020-02-20
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.